Io Biotech Inc (IOBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,879 | -46,570 | -42,107 | -3,748 | -12,042 |
| Depreciation Amortization | 2 | N/A | 1 | N/A | 0 |
| Accounts payable and accrued liabilities | 3,406 | 1,644 | 1,174 | 678 | N/A |
| Other Working Capital | -776 | -1,851 | -306 | -11 | 148 |
| Other Operating Activity | 24,601 | 25,371 | 28,003 | -811 | 1,938 |
| Operating Cash Flow | $-40,646 | $-21,406 | $-13,235 | $-3,892 | $-9,956 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -153 | -3 | N/A | N/A | 0 |
| Investing Cash Flow | $-153 | $-3 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 115,115 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 137,836 | 65,408 | 65,408 | 65,408 | 5,102 |
| Financing Cash Flow | $252,951 | $65,408 | $65,408 | $65,408 | $5,102 |
| Exchange Rate Effect | -3,758 | -1,927 | -825 | -1,699 | 413 |
| Beginning Cash Position | 3,405 | 3,405 | 3,405 | 3,405 | 7,846 |
| End Cash Position | 211,799 | 45,477 | 54,753 | 63,222 | 3,405 |
| Net Cash Flow | $208,394 | $42,072 | $51,348 | $59,817 | $-4,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,646 | -21,406 | -13,235 | -3,892 | -9,956 |
| Capital Expenditure | -153 | -3 | N/A | N/A | N/A |
| Free Cash Flow | -40,799 | -21,409 | -13,235 | -3,892 | -9,956 |